Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047541 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70
A Phase 3 study of Ocular Hypertension and Open Angle Glaucoma, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00047541 is a Phase 3 study of Ocular Hypertension and Open Angle Glaucoma that has completed, run by Alcon Research. The trial reports 1 study location across 1 state.
The verdict
NCT00047541, a Phase 3 study of Ocular Hypertension and Open Angle Glaucoma, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
Conditions Studied
Interventions
- DRUG Alcon Investigational Agent
Study Locations (1)
Texas
- Clinical Trial Sites - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-02 |
| Est. Completion | 2003-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00047541
The ClinicalTrials.gov registry entry for NCT00047541 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ocular Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Alcon Investigational Agent is the first listed.
NCT00047541 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00047541 about?
NCT00047541 is a clinical study titled "Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70". To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
What is the current status of trial NCT00047541?
This trial is currently completed. It is a Phase 3 study. The study started on 2001-02. Estimated completion is 2003-11.
What conditions does trial NCT00047541 study?
This clinical trial studies the following conditions: Ocular Hypertension, Open Angle Glaucoma.
What interventions are being tested in trial NCT00047541?
The interventions under investigation include: Alcon Investigational Agent (DRUG).
Who is sponsoring clinical trial NCT00047541?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00047541 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ocular Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
RECRUITING · Phase 3
-
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
RECRUITING · Phase 3
-
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
RECRUITING · Phase 3
-
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
ACTIVE NOT RECRUITING · Phase 3
-
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
ACTIVE NOT RECRUITING · Phase 3
-
Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.